معرفی
Elise Mirjam Koch is a Researcher at the Centre for Precision Psychiatry, affiliated with the University of Oslo and Oslo University Hospital. Her work focuses on psychiatric genetics, precision medicine, and the genetic basis of neuropsychiatric conditions. Key research areas include polygenic risk scoring, drug repurposing for neurodevelopmental disorders, and pharmacogenetic determinants of treatment outcomes.
Her research employs real-world data integration and genomic analysis to address challenges in schizophrenia, autism spectrum disorder, and Alzheimer's disease. Notable contributions include studies on clozapine metabolism genetics, cannabis-psychosis associations, and APOE's role in neurodegeneration. Koch collaborates extensively with international teams across multiple psychiatric and neuroimaging studies.
Leveraging epidemiological and neuroimaging methods, her work bridges genetic discoveries with clinical applications, aiming to improve personalized treatment strategies. Current projects emphasize optimizing antipsychotic dosing through genetic markers and evaluating CNS medication impacts on cognition over time.
